ĐÁNH GIÁ MỨC ĐỘ NẶNG VÀ PHÂN TÍCH KẾT CỤC ĐIỀU TRỊ Ở BỆNH NHÂN VIÊM PHỔI CỘNG ĐỒNG QUA MỘT SỐ THANG ĐIỂM TẠI BỆNH VIỆN ĐA KHOA TRUNG ƯƠNG CẦN THƠ NĂM 2022-2023

Abstract

Background: Community-acquired pneumonia (CAP) is one of the acute lower respiratory tract infections with high morbidity and mortality. Early diagnosis and appropriate severity assessment help to select antibiotics treatment, and help to improve patient mortality. Objectives: To evaluate severity and relationship with treatment outcome in patients with community-acquired pneumonia through the CRB-65, CURB-65, ECURB-65 and PSI scores. Materials and methods: Cross-sectional, prospective descriptive study. To select a convenient sample of 91 patients diagnosed with CAP from October 2022 to October 2023. Results: The rates of CAP in the CRB652, CURB-653, ECURB-655, and PSIIV group were 12.1%; 6.6%; 10.9%; 52.7% with p<0.01. The rates of treatment failure outcomes in the CRB-65≥2, CURB-653, ECURB-655, and PSIIV groups were 45.4%; 50%; 40%; 12.5% with p<0.05. The area under the curve in prediction of treatment failure through the CRB-65, CURB-65, ECURB-65, and PSI scores were 0.905 (p<0.01); 0.894 (p=0.01); 0.927 (p<0.01) and 0.909 (p=0.01). Conclusions: The ECURB-65 score has good support for predicting treatment outcomes in hospitalized CAP patients with an AUC of 0.927. In addition, the CRB-65 score which is easy-to-remember also helps to predict clinical treatment outcomes with an AUC of 0.905.